Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

heparin

DBL HEPARIN SODIUM

heparin (DBL HEPARIN SODIUM) is a antithrombin-iii activator. Associated with Pfizer Australia Pty Ltd.

TGA: approved NMPA: clinical trials
Patents linked 10
Pipeline programs 11
News articles 0
Drug details — heparin
Class
—
Route
—
Patents
10
Programs
11
Data quality
0.81
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

heparin (DBL HEPARIN SODIUM) is a antithrombin-iii activator. Associated with Pfizer Australia Pty Ltd.

Key facts

INN heparin
Brand DBL HEPARIN SODIUM
Mechanism Antithrombin-III activator
Target Antithrombin-III
Originator Pfizer Australia Pty Ltd

Mechanism of action

Antithrombin-III activator

Primary target: Antithrombin-III

Approval history

Authority Status Date
TGA approved —
NMPA clinical trials —

Pipeline programs

Search pipeline Sponsor programs
  1. ATN-108 Phase 3 · Anaxis Pharma · Acquired Antithrombin Deficiency (Heparin Resistance)
  2. HEPARIN , NADROPARIN Phase 3 · Disc Medicine · All patients who receive ECMO treatment during the study per
  3. VISIPAQUE d’I/mL for Knee OsteoArthritis Phase 3 · PARItec · Knee OsteoArthritis
  4. APHP240923 Phase 2 · PARItec · Sepsis
  5. Heparin Phase 2 · Chinese Academy of · Thromboprophylaxis
  6. Heparin and Rivaroxaban Phase 2 · First People's Hospital · Liver Cirrhosis
  7. Low Molecular Weight Heparin (LMWH) Phase 2 · Cardiff Oncology · Cancer
  8. Low-Molecular-Weight Heparins Calcium Injection Approved · Chinese Academy of · Pneumonia

Related & competitor drugs

Browse all drugs
  1. enoxaparin sodium Blood and blood forming organs (B01)
  2. fondaparinux sodium Blood and blood forming organs (B01)
  3. heparin sodium Antithrombin-III activator
  4. ardeparin sodium Antithrombin-III activator
  5. dalteparin sodium Antithrombin-III activator
  6. danaparoid sodium Antithrombin-III activator

Related patents

Browse patents Pfizer Australia Pty Ltd patent hub

  1. US 12319752

    Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12036234

    Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11174288

    Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10251955

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9700628

    Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8617557

    Antibody fusion with IL-12 proteins with disrupted heparin-binding activity

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7264799

    Use of heparinases to decrease inflammatory response

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 6787365

    Inhibition of L-selectin and P-selectin mediated binding using heparin

    Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6596705

    Inhibition of L-selectin and P-selection mediated binding using heparin

    Expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6051549

    Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof

    Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is heparin?

heparin (DBL HEPARIN SODIUM) is a antithrombin-iii activator. Associated with Pfizer Australia Pty Ltd.

What is the brand name for heparin?

DBL HEPARIN SODIUM is a marketed brand name for heparin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.